|
|
||||||||




*
Structural Biology Section and
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD 20852; and
Institut fur Anthropologie und Humangenetik der Universitat Munchen, Munich, Germany
The CD94/NKG2 receptors expressed by subpopulations of NK cells and T cells have been implicated as receptors for a broad range of both classical and nonclassical HLA class I molecules. To examine the ligand specificity of CD94/NKG2 proteins, a soluble heterodimeric form of the receptor was produced and used in direct binding studies with cells expressing defined HLA class I/peptide complexes. We confirm that CD94/NKG2A specifically interacts with HLA-E and demonstrate that this interaction is dependent on the association of HLA-E with peptide. Moreover, no interaction between CD94/NKG2A and classical HLA class I molecules was observed, as assayed by direct binding of the soluble receptor or by functional assays using CD94/NKG2A+ NK cells. The role of the peptide associated with HLA-E in the interaction between HLA-E and CD94/NKG2A was also assessed. All class I leader sequence peptides tested bound to HLA-E and were recognized by CD94/NKG2A. However, amino acid variations in class I leader sequences affected the stability of HLA-E. Additionally, not all HLA-E/peptide complexes examined were recognized by CD94/NKG2A. Thus CD94/NKG2A recognition of HLA-E is controlled by peptide at two levels; first, peptide must stabilize HLA-E and promote cell surface expression, and second, the HLA-E/peptide complex must form the ligand for CD94/NKG2A.
This article has been cited by other articles:
![]() |
Y. KAWAGUCHI, K. KONO, Y. MIZUKAMI, K. MIMURA, and H. FUJII Mechanisms of Escape from Trastuzumab-mediated ADCC in Esophageal Squamous Cell Carcinoma: Relation to Susceptibility to Perforin-granzyme Anticancer Res, June 1, 2009; 29(6): 2137 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lo Monaco, L. Sibilio, E. Melucci, E. Tremante, M. Suchanek, V. Horejsi, A. Martayan, and P. Giacomini HLA-E: Strong Association with {beta}2-Microglobulin and Surface Expression in the Absence of HLA Class I Signal Sequence-Derived Peptides J. Immunol., October 15, 2008; 181(8): 5442 - 5450. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Petrie, C. S. Clements, J. Lin, L. C. Sullivan, D. Johnson, T. Huyton, A. Heroux, H. L. Hoare, T. Beddoe, H. H. Reid, et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence J. Exp. Med., March 17, 2008; 205(3): 725 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, M. Bonaparte, J. Sacks, J. Guterman, M. Fogli, D. Mavilio, and E. Barker HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts Blood, August 15, 2007; 110(4): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masilamani, C. Nguyen, J. Kabat, F. Borrego, and J. E. Coligan CD94/NKG2A Inhibits NK Cell Activation by Disrupting the Actin Network at the Immunological Synapse J. Immunol., September 15, 2006; 177(6): 3590 - 3596. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Derre, M. Corvaisier, B. Charreau, A. Moreau, E. Godefroy, A. Moreau-Aubry, F. Jotereau, and N. Gervois Expression and Release of HLA-E by Melanoma Cells and Melanocytes: Potential Impact on the Response of Cytotoxic Effector Cells. J. Immunol., September 1, 2006; 177(5): 3100 - 3107. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Clements, L. Kjer-Nielsen, L. Kostenko, H. L. Hoare, M. A. Dunstone, E. Moses, K. Freed, A. G. Brooks, J. Rossjohn, and J. McCluskey Crystal structure of HLA-G: A nonclassical MHC class I molecule expressed at the fetal-maternal interface PNAS, March 1, 2005; 102(9): 3360 - 3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Bonaparte and E. Barker Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules Blood, October 1, 2004; 104(7): 2087 - 2094. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. S. Huang, P. Borszcz, S. Sidobre, M. Kronenberg, and K. P. Kane CD1d1 Displayed on Cell Size Beads Identifies and Enriches an NK Cell Population Negatively Regulated by CD1d1 J. Immunol., May 1, 2004; 172(9): 5304 - 5312. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Bland, M. K. Lemberg, A. J. McMichael, B. Martoglio, and V. M. Braud Requirement of the Proteasome for the Trimming of Signal Peptide-derived Epitopes Presented by the Nonclassical Major Histocompatibility Complex Class I Molecule HLA-E J. Biol. Chem., September 5, 2003; 278(36): 33747 - 33752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Miller, D. A. Weber, C. Ibegbu, J. Pohl, J. D. Altman, and P. E. Jensen Analysis of HLA-E Peptide-Binding Specificity and Contact Residues in Bound Peptide Required for Recognition by CD94/NKG2 J. Immunol., August 1, 2003; 171(3): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Shilling, K. L. McQueen, N. W. Cheng, J. A. Shizuru, R. S. Negrin, and P. Parham Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation Blood, May 1, 2003; 101(9): 3730 - 3740. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gunturi, R. E. Berg, and J. Forman Preferential Survival of CD8 T and NK Cells Expressing High Levels of CD94 J. Immunol., February 15, 2003; 170(4): 1737 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Flores-Villanueva, H. Hendel, S. Caillat-Zucman, J. Rappaport, A. Burgos-Tiburcio, S. Bertin-Maghit, J. A. Ruiz-Morales, M. E. Teran, J. Rodriguez-Tafur, and J.-F. Zagury Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AIDS Disease Development J. Immunol., February 15, 2003; 170(4): 1925 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Long and S. Rajagopalan Stress Signals Activate Natural Killer Cells J. Exp. Med., December 2, 2002; 196(11): 1399 - 1402. [Full Text] [PDF] |
||||
![]() |
J. Michaelsson, C. Teixeira de Matos, A. Achour, L. L. Lanier, K. Karre, and K. Soderstrom A Signal Peptide Derived from hsp60 Binds HLA-E and Interferes with CD94/NKG2A Recognition J. Exp. Med., December 2, 2002; 196(11): 1403 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Radaev, M. Kattah, Z. Zou, M. Colonna, and P. D. Sun Making Sense of the Diverse Ligand Recognition by NKG2D J. Immunol., December 1, 2002; 169(11): 6279 - 6285. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Hsu, X.-R. Liu, A. Selvakumar, E. Mickelson, R. J. O'Reilly, and B. Dupont Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets J. Immunol., November 1, 2002; 169(9): 5118 - 5129. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Shilling, N. Young, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, D. Tyan, and P. Parham Genetic Control of Human NK Cell Repertoire J. Immunol., July 1, 2002; 169(1): 239 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dulphy, C. Rabian, C. Douay, O. Flinois, S. Laoussadi, J. Kuipers, R. Tamouza, D. Charron, and A. Toubert Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis Int. Immunol., May 1, 2002; 14(5): 471 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sharland, A. Patel, J. H. Lee, A. E. Cestra, S. Saidman, and G. L. Waneck Genetically Modified HLA Class I Molecules Able to Inhibit Human NK Cells Without Provoking Alloreactive CD8+ CTLs J. Immunol., April 1, 2002; 168(7): 3266 - 3274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barakonyi, K. T. Kovacs, E. Miko, L. Szereday, P. Varga, and J. Szekeres-Bartho Recognition of Nonclassical HLA Class I Antigens by {gamma}{delta} T Cells During Pregnancy J. Immunol., March 15, 2002; 168(6): 2683 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Shum, L. R. Flodin, D. G. Muir, R. Rajalingam, S. I. Khakoo, S. Cleland, L. A. Guethlein, M. Uhrberg, and P. Parham Conservation and Variation in Human and Common Chimpanzee CD94 and NKG2 Genes J. Immunol., January 1, 2002; 168(1): 240 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matsumoto, K. Tajima, M. Mitsuki, and K. Yamamoto H-2 allele specificity of the NK cell C-type lectin-like MHC class I receptor Ly49A visualized by soluble Ly49A tetramer Int. Immunol., May 1, 2001; 13(5): 615 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gardiner, L. A. Guethlein, H. G. Shilling, M. Pando, W. H. Carr, R. Rajalingam, C. Vilches, and P. Parham Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism J. Immunol., March 1, 2001; 166(5): 2992 - 3001. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gays, K. P. Fraser, J. A. Toomey, A. G. Diamond, M. M. Millrain, P. J. Dyson, and C. G. Brooks Functional Analysis of the Molecular Factors Controlling Qa1-Mediated Protection of Target Cells from NK Lysis J. Immunol., February 1, 2001; 166(3): 1601 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Chung, K. Natarajan, L. F. Boyd, J. Tormo, R. A. Mariuzza, W. M. Yokoyama, and D. H. Margulies Mapping the Ligand of the NK Inhibitory Receptor Ly49A on Living Cells J. Immunol., December 15, 2000; 165(12): 6922 - 6932. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Watzl, C. C. Stebbins, and E. O. Long Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244) J. Immunol., October 1, 2000; 165(7): 3545 - 3548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kraft, R. E. Vance, J. Pohl, A. M. Martin, D. H. Raulet, and P. E. Jensen Analysis of Qa-1bPeptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1-Peptide Complexes J. Exp. Med., September 5, 2000; 192(5): 613 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ulbrecht, S. Martinozzi, M. Grzeschik, H. Hengel, J. W. Ellwart, M. Pla, and E. H. Weiss Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis J. Immunol., May 15, 2000; 164(10): 5019 - 5022. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Idris, H. R. C. Smith, L. H. Mason, J. R. Ortaldo, A. A. Scalzo, and W. M. Yokoyama The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing PNAS, May 25, 1999; 96(11): 6330 - 6335. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Lanier Natural killer cells fertile with receptors for HLA-G? PNAS, May 11, 1999; 96(10): 5343 - 5345. [Full Text] [PDF] |
||||
![]() |
J. Stevens, R. C. Jones, R. S. Bordoli, J. Trowsdale, S. J. Gaskell, G. W. Butcher, and E. Joly Peptide Specificity of RT1-A1c, an Inhibitory Rat Major Histocompatibility Complex Class I Natural Killer Cell Ligand J. Biol. Chem., September 15, 2000; 275(38): 29217 - 29224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Snyder, J. Wang, J. F. Waring, and G. D. Ginder Identification of CCAAT Displacement Protein (CDP/cut) as a Locus-specific Repressor of Major Histocompatibility Complex Gene Expression in Human Tumor Cells J. Biol. Chem., February 9, 2001; 276(7): 5323 - 5330. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |